Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial

BACKGROUND: Kidney pain is a common complication in patients with autosomal dominant polycystic kidney disease (ADPKD), and data from the TEMPO 3:4 trial suggested that tolvaptan, a vasopressin V2 receptor antagonist, may have a positive effect on kidney pain in this patient group. Because pain is d...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Kidney Dis
Asıl Yazarlar: Casteleijn, Niek F., Blais, Jaime D., Chapman, Arlene B., Czerwiec, Frank S., Devuyst, Olivier, Higashihara, Eiji, Leliveld, Anna M., Ouyang, John, Perrone, Ronald D., Torres, Vicente E., Gansevoort, Ron T.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5497700/
https://ncbi.nlm.nih.gov/pubmed/27856088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.ajkd.2016.08.028
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller